Mordor Intelligence announces the publication of their research report on the immunoassays market. The report titled, “Global Immunoassays Market Growth, Trends & Forecasts (2016 – 2020)” discusses the current landscape and outlook of the said market. Mordor Intelligence is a global market research and consulting firm.
The global immunoassays market was estimated at USD 16,374.1 million in 2015 and it is expected to reach USD 28,535.5 million by 2021, growing at a CAGR of 9.7% during the forecast period.
Increase demand for non-invasive diagnostics with high sensitivity and specificity is boosting the growth of global immunoassays market. North America is currently the largest immunoassays market globally, followed by Europe. The Asia-Pacific region has great market potential due to the increasing healthcare spending in countries of this region.
The global immunoassays market has been segmented based on Technology (Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Radio Immunoassay, Nephelometric Immunoassay and Others), by Therapeutic Area (Cardiology, Thyroid, Autoimmune Diseases, Oncology, Infectious diseases, Hematology, Allergies and Others), by End users (Hospitals, Centralized Laboratories, Academic Institutions, Pharma & Biotech Firms, Contract Research Organizations and Others) and by geography (North America, Europe, APAC, Middle East and Africa, Latin America and Rest of the World).
The leading companies that dominate the market are Abbott Laboratories, Inc, Akers Biosciences, Inc., Becton Dickinson & Company, Biomérieux, Danaher Corporation (Beckman Coulter), Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe), Intrinsic LifeSciences and others.
The report is an amalgamation of the current market scenario, its prospects and forces driving and restraining the market growth. The report highlights the North American, European, Asia-Pacific, Latin American and Middle East & African markets.